title: The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice.
abstract: IGF-binding protein (IGFBP)-2 overexpression confers resistance to high-fat feeding and inhibits the differentiation of preadipocytes in vitro. However, whether administration of IGFBP-2 can regulate adipogenesis in vivo and the domains that mediate this response have not been defined. IGFBP-2 contains 2 heparin-binding domains (HBD), which are localized in the linker region (HBD1) and C-terminal region (HBD2) of IGFBP-2. To determine the relative importance of these domains, we used synthetic peptides as well as mutagenesis. Both HBD1 and HBD2 peptides inhibited preadipocyte differentiation, but the HBD2 peptide was more effective. Selective substitution of charged residues in the HBD1 or HBD2 regions attenuated the ability of the full-length protein to inhibit cell differentiation, but the HBD2 mutant had the greatest reduction. To determine their activities in vivo, pegylated forms of each peptide were administered to IGFBP-2(-/-) mice for 12 weeks. Magnetic resonance imaging scanning showed that only the HBD2 peptide significantly reduced (48 ± 9%, P < .05) gain in total fat mass. Both inguinal (32 ± 7%, P < .01) and visceral fat (44 ± 7%, P < .01) were significantly decreased by HBD2 whereas HBD1 reduced only visceral fat accumulation (24 ± 5%, P < .05). The HBD2 peptide was more effective peptide in reducing triglyceride content and serum adiponectin, but only the HBD2 peptide increased serum leptin. These findings demonstrate that the HBD2 domain of IGFBP-2 is the primary region that accounts for its ability to inhibit adipogenesis and that a peptide encompassing this region has activity that is comparable with native IGFBP-2.
authors: MD, CB no. 7170, 8024 Burnett Womack, Division of Endocrinology, University of North Carolina, Chapel Hill, NC 27599-7170. david_clemmons@med.unc.edu.
authors: Gang
authors: G
authors: Xi
authors: Melissa A
authors: MA
authors: Solum
authors: Christine
authors: C
authors: Wai
authors: Laura A
authors: LA
authors: Maile
authors: Clifford J
authors: CJ
authors: Rosen
authors: David R
authors: DR
authors: Clemmons
mesh_terms: D017667:Adipocytes / Q000166:cytology* / Q000378:metabolism; D000273:Adipose Tissue / Q000502:physiology*; D000818:Animals; D002454:Cell Differentiation; D002478:Cells, Cultured; D004822:Epididymis / Q000166:cytology; D006493:Heparin / Q000378:metabolism*; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000235:genetics / Q000378:metabolism*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D009154:Mutation; D017434:Protein Structure, Tertiary
chemical_list: D018971:Insulin-Like Growth Factor Binding Protein 2; D006493:Heparin
references: Endocr Rev. 2001 Dec;22(6):800-17
references: 11739334
references: Metabolism. 1998 Dec;47(12):1490-3
references: 9867079
references: J Clin Endocrinol Metab. 1998 May;83(5):1467-71
references: 9589640
references: J Clin Endocrinol Metab. 2009 Dec;94(12):5093-101
references: 19846739
references: J Pediatr Endocrinol Metab. 2004 May;17(5):749-57
references: 15237710
references: Obesity (Silver Spring). 2012 Jul;20(7):1469-73
references: 22522884
references: Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):593-7
references: 17372257
references: Biochem Pharmacol. 2005 Nov 15;70(10):1469-78
references: 16197920
references: Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E287-98
references: 20501873
references: Growth Regul. 1993 Mar;3(1):14-7
references: 7683516
references: Mol Endocrinol. 2008 Sep;22(9):2162-75
references: 18606861
references: J Bone Miner Res. 2012 Feb;27(2):390-400
references: 22006816
references: Obesity (Silver Spring). 2007 Apr;15(4):879-86
references: 17426323
references: Horm Metab Res. 2010 Oct;42(11):787-91
references: 20730703
references: J Biol Chem. 1996 Jun 7;271(23):13523-9
references: 8662813
references: Diabetes. 2007 Feb;56(2):285-94
references: 17259371
references: Cell Metab. 2005 Sep;2(3):165-77
references: 16154099
references: J Clin Endocrinol Metab. 2010 Feb;95(2):864-71
references: 20061427
references: Int J Obes Relat Metab Disord. 1997 May;21(5):355-9
references: 9152736
references: Best Pract Res Clin Endocrinol Metab. 2011 Feb;25(1):101-13
references: 21396577
references: J Biol Chem. 2000 Jun 16;275(24):18188-94
references: 10766744
references: J Clin Endocrinol Metab. 2006 Sep;91(9):3287-95
references: 16787980
references: Obesity (Silver Spring). 2010 Oct;18(10):2055-7
references: 20134415
references: Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E654-63
references: 19141684
references: Endocr Rev. 2002 Dec;23(6):824-54
references: 12466191
references: Mol Cell Endocrinol. 2012 Sep 25;361(1-2):172-8
references: 22548717
references: J Am Geriatr Soc. 2009 Jul;57(7):1213-8
references: 19558480
references: Mol Cell Biol. 2012 Oct;32(20):4116-30
references: 22869525
references: J Biol Chem. 2011 Apr 22;286(16):14670-80
references: 21372140
references: Biochemistry. 2007 Dec 4;46(48):13720-32
references: 17985932
references: Endocrinology. 2005 Oct;146(10):4445-55
references: 15994346
references: Endocrinology. 1994 Nov;135(5):1863-8
references: 7525256
references: Trends Endocrinol Metab. 2009 May;20(4):153-62
references: 19349193
references: Endocr J. 2012;59(8):725-33
references: 22673199
references: Endocrinology. 2008 May;149(5):2051-61
references: 18276763
references: Physiol Genomics. 2011 Feb 24;43(4):199-212
references: 21156834
references: Cancer Causes Control. 2010 Nov;21(11):1829-42
references: 20652394
references: J Mol Biol. 2006 Dec 8;364(4):690-704
references: 17020769
references: Endocrinology. 1993 Dec;133(6):2624-31
references: 7694843
references: J Endocrinol. 2002 Oct;175(1):19-31
references: 12379487
references: Diabetologia. 2012 Mar;55(3):752-62
references: 22202803
references: Cell Metab. 2010 Jan;11(1):11-22
references: 20074524
references: J Nutr Sci Vitaminol (Tokyo). 1992 Oct;38(5):517-21
references: 1294711
references: J Clin Endocrinol Metab. 1997 Jul;82(7):2084-92
references: 9215276
references: Endocrinology. 2001 May;142(5):2147
references: 11316783
references: Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):371-6
references: 16915540
references: Endocrinology. 1995 Oct;136(10):4168-73
references: 7545099
references: Prog Growth Factor Res. 1991;3(4):243-66
references: 1725860
references: Cancer Biol Ther. 2006 Feb;5(2):189-97
references: 16357519
references: Cancer Causes Control. 2001 Dec;12(10):951-8
references: 11808715
references: J Mol Endocrinol. 2004 Jun;32(3):859-68
references: 15171717
references: Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10553-7
references: 7504269